{
  "paper": {
    "doi": null,
    "pmcid": "PMC12757875",
    "title": "The DDR-immune fitness score: a biomarker for guiding parp and immunotherapy synergy in extensive-stage small cell lung cancer",
    "authors": [],
    "journal": null,
    "year": null,
    "study_type": "systematic review and biomarker development",
    "eco_type": "computational modeling"
  },
  "extraction_provenance": {
    "extraction_pipeline": {
      "name": "medlit_pass1_extract",
      "version": "0.1.0",
      "git_commit": "b806ec36126690c24218bfa2f6999b594dcf4d10",
      "git_commit_short": "b806ec3",
      "git_branch": "ingest-refactor",
      "git_dirty": true,
      "repo_url": "https://github.com/org/medlit"
    },
    "models": {
      "llm": {
        "name": "claude-sonnet-4-20250514",
        "version": ""
      }
    },
    "prompt": {
      "version": "v1",
      "template": "medlit_extraction_v1",
      "checksum": "sha256:f94cc0ab23940d18"
    },
    "execution": {
      "timestamp": "2026-02-23T17:40:23.737411Z",
      "hostname": "unknown",
      "python_version": "3.13.3",
      "duration_seconds": 42.94
    },
    "entity_resolution": null,
    "model_info": null
  },
  "entities": [
    {
      "id": "disease_1",
      "class": "Disease",
      "name": "extensive-stage small-cell lung cancer",
      "synonyms": [
        "ES-SCLC",
        "extensive-stage SCLC"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": "C0149925",
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "disease_2",
      "class": "Disease",
      "name": "small cell lung cancer",
      "synonyms": [
        "SCLC"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": "C0149925",
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "biomarker_1",
      "class": "Biomarker",
      "name": "DDR-Immune Fitness score",
      "synonyms": [
        "DDR-IF score",
        "DDR-IF"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "biomarker_2",
      "class": "Biomarker",
      "name": "homologous recombination deficiency",
      "synonyms": [
        "HRD"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "biomarker_3",
      "class": "Biomarker",
      "name": "tumor mutational burden",
      "synonyms": [
        "TMB"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "biomarker_4",
      "class": "Biomarker",
      "name": "STING pathway activity",
      "synonyms": [
        "STING activation"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "drug_1",
      "class": "Drug",
      "name": "PARP inhibitor",
      "synonyms": [
        "PARPi",
        "PARP inhibitors"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": "1598392",
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "drug_2",
      "class": "Drug",
      "name": "immune checkpoint blocker",
      "synonyms": [
        "ICB",
        "immune checkpoint blockers"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "drug_3",
      "class": "Drug",
      "name": "PD-L1 inhibitor",
      "synonyms": [
        "anti-PD-L1"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "gene_1",
      "class": "Gene",
      "name": "ATM",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:795",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "gene_2",
      "class": "Gene",
      "name": "BRCA1",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:1100",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "gene_3",
      "class": "Gene",
      "name": "BRCA2",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:1101",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "gene_4",
      "class": "Gene",
      "name": "PARP1",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:270",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "gene_5",
      "class": "Gene",
      "name": "RAD51",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:9817",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "gene_6",
      "class": "Gene",
      "name": "SLFN11",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:31119",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "gene_7",
      "class": "Gene",
      "name": "STING",
      "synonyms": [
        "TMEM173"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:27962",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "pathway_1",
      "class": "Pathway",
      "name": "DNA damage repair pathway",
      "synonyms": [
        "DDR pathway"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "pathway_2",
      "class": "Pathway",
      "name": "cGAS-STING pathway",
      "synonyms": [
        "STING pathway"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "cell_type_1",
      "class": "CellType",
      "name": "CD8+ T cell",
      "synonyms": [
        "CD8+ cytotoxic T cell"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "treatment_1",
      "class": "Treatment",
      "name": "PARP-ICB combination",
      "synonyms": [
        "PARP-ICB",
        "DDR-ICB"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    }
  ],
  "evidence_entities": [
    {
      "id": "paper_1:background:1:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "paper_1",
      "text_span_id": "background_1",
      "text": "DDR-IF-high tumors were characterized by a distinct biological profile, including (i) transcriptional exhaustion of the cGAS-STING innate immune pathway (p < 0.001), (ii) significantly reduced CD8+ T cell infiltration (2.3-fold fewer, p = 0.004), and (iii) a superior pooled objective response rate to PARP-ICB combinations (42% vs 18%; risk ratio 2.3, 95% CI 1.3-4.2; p = 0.003)",
      "confidence": 0.95,
      "extraction_method": "llm",
      "study_type": "systematic review and biomarker development",
      "eco_type": "computational modeling",
      "source": "extracted"
    },
    {
      "id": "paper_1:methods:1:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "paper_1",
      "text_span_id": "methods_1",
      "text": "The final DDR-IF score was defined using standardized coefficients: DDR-IF = 0.4 \u00d7 (HRD score) + 0.35 \u00d7 log10(TMB + 1) + 0.25 \u00d7 (STING activation score)",
      "confidence": 0.98,
      "extraction_method": "llm",
      "study_type": "systematic review and biomarker development",
      "eco_type": "computational modeling",
      "source": "extracted"
    },
    {
      "id": "paper_1:results:1:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "paper_1",
      "text_span_id": "results_1",
      "text": "A meta-analysis of six trials (2020\u20132024) confirmed that DDR-IF-high tumors (e.g., ATM/BRCA1/2-altered) show a 2.3-fold higher ORR to PARP-ICB versus DDR-IF-low (42% vs. 18%, p=0.003)",
      "confidence": 0.92,
      "extraction_method": "llm",
      "study_type": "systematic review and biomarker development",
      "eco_type": "computational modeling",
      "source": "extracted"
    },
    {
      "id": "paper_1:results:2:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "paper_1",
      "text_span_id": "results_2",
      "text": "the DDR-IF score demonstrated superior predictive power for PARP-ICB response (AUROC = 0.81) compared to SLFN11 expression alone (AUROC = 0.64), ATM mutation status (AUROC = 0.59), or a simple TMB-PD-L1 composite model (AUROC = 0.72)",
      "confidence": 0.9,
      "extraction_method": "llm",
      "study_type": "systematic review and biomarker development",
      "eco_type": "computational modeling",
      "source": "extracted"
    }
  ],
  "relationships": [
    {
      "subject": "biomarker_1",
      "predicate": "INDICATES",
      "object": "treatment_1",
      "evidence_ids": [
        "paper_1:background:1:llm",
        "paper_1:results:1:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.95,
      "properties": {
        "response_rate": "42% vs 18%",
        "risk_ratio": "2.3 (95% CI 1.3-4.2)"
      },
      "section": "results",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "biomarker_2",
      "predicate": "SUBTYPE_OF",
      "object": "biomarker_1",
      "evidence_ids": [
        "paper_1:methods:1:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.98,
      "properties": {
        "weight": "0.4"
      },
      "section": "methods",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "biomarker_3",
      "predicate": "SUBTYPE_OF",
      "object": "biomarker_1",
      "evidence_ids": [
        "paper_1:methods:1:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.98,
      "properties": {
        "weight": "0.35"
      },
      "section": "methods",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "biomarker_4",
      "predicate": "SUBTYPE_OF",
      "object": "biomarker_1",
      "evidence_ids": [
        "paper_1:methods:1:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.98,
      "properties": {
        "weight": "0.25"
      },
      "section": "methods",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "biomarker_1",
      "predicate": "ASSOCIATED_WITH",
      "object": "cell_type_1",
      "evidence_ids": [
        "paper_1:background:1:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.92,
      "properties": {
        "relationship_type": "reduced infiltration",
        "fold_change": "2.3-fold fewer"
      },
      "section": "results",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "treatment_1",
      "predicate": "TREATS",
      "object": "disease_1",
      "evidence_ids": [
        "paper_1:background:1:llm",
        "paper_1:results:1:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.9,
      "properties": {
        "response_rate": "42% in DDR-IF-high tumors"
      },
      "section": "results",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "gene_1",
      "predicate": "ASSOCIATED_WITH",
      "object": "biomarker_2",
      "evidence_ids": [
        "paper_1:results:1:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.85,
      "properties": {
        "mutation_frequency": "11.2%"
      },
      "section": "results",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "gene_2",
      "predicate": "ASSOCIATED_WITH",
      "object": "biomarker_2",
      "evidence_ids": [
        "paper_1:results:1:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.85,
      "properties": {
        "mutation_frequency": "6.7%"
      },
      "section": "results",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "gene_3",
      "predicate": "ASSOCIATED_WITH",
      "object": "biomarker_2",
      "evidence_ids": [
        "paper_1:results:1:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.85,
      "properties": {
        "mutation_frequency": "6.7%"
      },
      "section": "results",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "pathway_2",
      "predicate": "ASSOCIATED_WITH",
      "object": "biomarker_4",
      "evidence_ids": [
        "paper_1:background:1:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.95,
      "properties": {
        "relationship_type": "exhaustion"
      },
      "section": "results",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    }
  ],
  "notes": [
    "The DDR-IF score is described as exploratory and requires prospective validation",
    "The study integrated data from 82 SCLC tumors and six phase II trials",
    "DDR-IF-high tumors showed superior response to PARP-ICB combinations but reduced immune infiltration"
  ]
}